0:000:00
<p>Another knock against the antiplatelet/anticoagulant combo, polypills in HF, the physical exam of the future, and the problem of underpowered trials that even Bayesian analyses cannot rescue are the topics John Mandrola, MD, discusses in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>.</p> <p>To read a partial transcript or to comment, visit:</p> <p>https://www.medscape.com/twic</p> <p><strong>I Listener Feedback</strong></p> <ul> <li><strong>Trends Study</strong> <strong>https://www.heartrhythmjournal.com/article/S1547-5271(11)00496-6/fulltext</strong></li> </ul> <p><strong>II Another knock against the Antiplatelet/Anticoagulation combination</strong></p> <p><strong>"Antiplatelet Plus Oral Anticoagulant Lowers Stroke, Raises Bleeding Risk"</strong> <strong>https://www.medscape.com/viewarticle/antiplatelet-plus-oral-anticoagulant-lowers-stroke-raises-2025a1000re0</strong></p> <ul> <li><strong>ATIS-NVAF Trial</strong> <strong>https://ja...